Form 4 · Filed Jul 10, 2026, 08:18 PM UTC
AGIO/AGIOS PHARMACEUTICALS, INC.
Backstrom Jay T. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | A | other | 1,447 | $0 | — | 1,447 |
| Jul 8, 2026 | M | other | 1,447 | — | — | 2,894 |
Source: SEC EDGAR raw filing ↗ · Accession 0001439222-26-000112